Markel Group Inc. Purchases 12,283 Shares of Xylem Inc. $XYL

Markel Group Inc. acquired a new position in Xylem Inc. (NYSE:XYL) in the 3rd quarter, HoldingsChannel reports. The fund acquired 12,283 shares of the industrial products company’s stock, valued at approximately $1,244,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in XYL. BlackRock Inc. purchased a new stake in Xylem during the second quarter valued at about $2,959,730,000. State Street Corp boosted its position in Xylem by 2.4% during the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the period. XXEC Inc. bought a new position in Xylem during the second quarter worth about $850,841,000. Swedbank AB increased its stake in shares of Xylem by 0.3% in the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock worth $660,444,000 after purchasing an additional 18,759 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in shares of Xylem by 1.1% in the first quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock worth $569,207,000 after purchasing an additional 53,210 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

NYSE:XYL opened at $96.08 on Wednesday. The business’s fifty day moving average is $104.36 and its 200 day moving average is $117.13. The firm has a market cap of $22.04 billion, a price-to-earnings ratio of 21.26, a PEG ratio of 1.62 and a beta of 1.01. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.02 and a current ratio of 1.39. Xylem Inc. has a 52-week low of $87.40 and a 52-week high of $152.43.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. During the same quarter in the prior year, the business earned $1.37 EPS. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. Research analysts predict that Xylem Inc. will post 5.45 EPS for the current year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.8%. Xylem’s dividend payout ratio is currently 38.05%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Stifel Nicolaus lowered their price target on shares of Xylem from $141.00 to $114.00 and set a “buy” rating on the stock in a research report on Wednesday, October 28th. UBS Group dropped their price target on shares of Xylem from $112.00 to $99.00 and set a “neutral” rating on the stock in a research note on Thursday, October 29th. Royal Bank Of Canada cut their price objective on shares of Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a report on Wednesday, October 28th. BNP Paribas Exane reduced their price objective on shares of Xylem from $145.00 to $135.00 and set an “outperform” rating for the company in a research note on Wednesday, October 28th. Finally, Wolfe Research began coverage on shares of Xylem in a research note on Tuesday, September 15th. They issued a “peer perform” rating for the company. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $121.31.

Insider Activity

In other news, Director D Koch purchased 11,000 shares of the stock in a transaction dated Thursday, October 29th. The shares were purchased at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the acquisition, the director owned 12,247 shares in the company, valued at $1,097,331.20. This represents a 882.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.32% of the company’s stock.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.